Bio-View Balance Sheet Health
Financial Health criteria checks 6/6
Bio-View has a total shareholder equity of ₪29.3M and total debt of ₪0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₪42.7M and ₪13.4M respectively. Bio-View's EBIT is ₪90.0K making its interest coverage ratio -0.1. It has cash and short-term investments of ₪16.8M.
Key information
0%
Debt to equity ratio
₪0
Debt
| Interest coverage ratio | -0.09x |
| Cash | ₪16.80m |
| Equity | ₪29.27m |
| Total liabilities | ₪13.41m |
| Total assets | ₪42.68m |
Recent financial health updates
Recent updates
Shareholders Will Probably Not Have Any Issues With Bio-View Ltd's (TLV:BIOV) CEO Compensation
Dec 04
Estimating The Intrinsic Value Of Bio-View Ltd (TLV:BIOV)
Feb 14Does BioView Ltd.'s (TLV:BIOV) Weak Fundamentals Mean That The Market Could Correct Its Share Price?
Jan 20What BioView Ltd.'s (TLV:BIOV) 35% Share Price Gain Is Not Telling You
Nov 29
Financial Position Analysis
Short Term Liabilities: BIOV's short term assets (₪33.8M) exceed its short term liabilities (₪11.7M).
Long Term Liabilities: BIOV's short term assets (₪33.8M) exceed its long term liabilities (₪1.7M).
Debt to Equity History and Analysis
Debt Level: BIOV is debt free.
Reducing Debt: BIOV had no debt 5 years ago.
Debt Coverage: BIOV has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: BIOV has no debt, therefore coverage of interest payments is not a concern.